ebomi
Colour theme
Sign in
Insider · CIK 0001259870

Biotech Target N V

CIK 0001259870 Name as filed on the most recent filing

Filed as Biotech Target N V (66)

86 transaction lines · from 66 filings · filed 2017-11-16 to 2024-11-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2021-02-23 P, Open-market purchase Molecular Templates, Inc.MTEM 2,653,031, acquired Open Form 4 filing 0000899243-21-008183
2021-02-18 P, Open-market purchase Molecular Templates, Inc.MTEM 14,999,991, acquired Open Form 4 filing 0000899243-21-007418
2021-02-01 P, Open-market purchase Molecular Templates, Inc.MTEM 935,344, acquired Open Form 4 filing 0000899243-21-004636
2021-01-29 P, Open-market purchase Molecular Templates, Inc.MTEM 955,000, acquired Open Form 4 filing 0000899243-21-003875
2020-12-10 P, Open-market purchase Molecular Templates, Inc.MTEM 2 lines 2,649,841, acquired Open Form 4 filing 0000899243-20-033533
2020-12-09 P, Open-market purchase Molecular Templates, Inc.MTEM 1,077,600, acquired Open Form 4 filing 0000899243-20-033533
2020-11-10 P, Open-market purchase Molecular Templates, Inc.MTEM 732,472, acquired Open Form 4 filing 0000899243-20-030775
2020-11-09 P, Open-market purchase Molecular Templates, Inc.MTEM 724,144, acquired Open Form 4 filing 0000899243-20-030775
2020-11-06 P, Open-market purchase Molecular Templates, Inc.MTEM 3,919,960, acquired Open Form 4 filing 0000899243-20-030625
2020-11-05 P, Open-market purchase Radius Health, Inc.RDUS 1,426,230, acquired Open Form 4 filing 0000899243-20-030614
2020-11-05 P, Open-market purchase Molecular Templates, Inc.MTEM 814,230, acquired Open Form 4 filing 0000899243-20-030625
2020-11-03 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 5,062,120, acquired Open Form 4 filing 0000899243-20-030389
2020-10-30 P, Open-market purchase Molecular Templates, Inc.MTEM 706,312, acquired Open Form 4 filing 0000899243-20-030364
2020-10-28 P, Open-market purchase Molecular Templates, Inc.MTEM 751,688, acquired Open Form 4 filing 0000899243-20-030364
2020-09-14 P, Open-market purchase Radius Health, Inc.RDUS 2,338,680, acquired Open Form 4 filing 0000899243-20-025283
2020-09-11 P, Open-market purchase Radius Health, Inc.RDUS 2,255,118, acquired Open Form 4 filing 0000899243-20-024980
2020-07-08 P, Open-market purchase Radius Health, Inc.RDUS 330,178, acquired Open Form 4 filing 0000899243-20-018807
2020-04-30 P, Open-market purchase Radius Health, Inc.RDUS 787,555, acquired Open Form 4 filing 0000899243-20-011906
2020-01-23 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 1,042,398, acquired Open Form 4 filing 0000899243-20-002016
2019-11-06 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,797,560, acquired Open Form 4 filing 0000899243-19-026965
2019-09-04 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,702,208, acquired Open Form 4 filing 0000899243-19-022997
2019-07-23 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,132,565, acquired Open Form 4 filing 0000899243-19-020344
2019-03-14 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,494,355, acquired Open Form 4 filing 0000899243-19-008014
2019-01-04 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 3,303,256, acquired Open Form 4 filing 0000899243-19-000685
2018-12-24 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 1,995,725, acquired Open Form 4 filing 0000899243-18-031655
2018-12-17 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,864,070, acquired Open Form 4 filing 0000899243-18-031388
2018-08-03 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,306,970, acquired Open Form 4 filing 0000899243-18-021471
2018-07-12 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,088,300, acquired Open Form 4 filing 0000899243-18-019836
2018-06-29 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 1,973,805, acquired Open Form 4 filing 0000899243-18-019108
2018-06-21 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,314,224, acquired Open Form 4 filing 0000899243-18-017843
2018-06-07 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,267,292, acquired Open Form 4 filing 0000899243-18-015926
2018-06-05 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,308,440, acquired Open Form 4 filing 0000899243-18-015413
2018-05-21 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 3,101,760, acquired Open Form 4 filing 0000899243-18-013665
2018-05-18 P, Open-market purchase Esperion Therapeutics, Inc.ESPR 2,112,010, acquired Open Form 4 filing 0000899243-18-013665
2017-11-15 P, Open-market purchase Cidara Therapeutics, Inc.CDTX 453,966, acquired Open Form 4 filing 0000899243-17-026540

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. BIOTECH TARGET N V, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001259870

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.